News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (20939)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Policy
Grünenthal Group Receives FDA’s Expedited Access Pathway Designation for VIVO
VIVO is a candidate from Gruenenthal’s innovative development-pipeline of surgical sealants.
February 1, 2018
·
3 min read
Business
BioPontis Alliance for Rare Diseases Announces Agreement with Massachusetts General Hospital on New Treatments for Huntington’s Disease
The strategic collaboration between MGH and BioPontis Alliance will advance discovery research being conducted at MGH,
February 1, 2018
·
4 min read
Business
IDEXX Laboratories Announces Fourth Quarter and Full Year 2017 Results
IDEXX Labs a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues of $506M for the fourth quarter of 2017.
February 1, 2018
·
63 min read
Business
Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian
Under the deal, Bedrosian will work with the company on several important projects primarily involving existing and new partnering efforts to expand and diversify opportunities.
February 1, 2018
·
2 min read
Business
Takeda Reports 3rd Quarter FY2017 Results
Underlying Revenue grew +6.7% year-to-date, with Takeda’s Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) posting strong underlying revenue growth of +14.5%..
February 1, 2018
·
4 min read
Business
$861M Tax Charge Pushes Boston Sci Into the Red for Q4
The company reported a GAAP loss of $615 million or ($0.45) per share.
February 1, 2018
·
54 min read
Business
Aerie Pharmaceuticals Announces Appointment of Tad Heitmann as Head of Communications
Aerie today announced the appointment of Tad Heitmann as Head of Communications, reporting to Judith Robertson, Aerie’s Chief Commercial Officer.
February 1, 2018
·
5 min read
Business
Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca
Under the terms of the agreement, Syndax and Astra will collaborate on a non-exclusive basis to evaluate the combination of the two drugs in multiple solid tumor types.
February 1, 2018
·
4 min read
Business
Nordic Nanovector Appoints Malene Brondberg as VP, Investor Relations and Corporate Communications
Malene will lead the engagement and communication with the investment community, media and analysts.
February 1, 2018
·
3 min read
Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE
The Company is obliged to repurchase approximately 49.21 million outstanding TDRs at a total consideration of approximately NT$219 million.
February 1, 2018
·
1 min read
Previous
2 of 17
Next